��������

Torsten Matthias is a seasoned professional in the field of biochemistry and diagnostics, holding significant leadership positions since 2000 as Founder and President of AESKU.GROUP, a company dedicated to innovative products and services for autoimmune disease detection and diagnosis. In addition to this role, Torsten Matthias is a Co-Funder of MODAG, which focuses on advanced treatments for neurodegenerative diseases through targeted therapeutics and diagnostics. Previously, Torsten Matthias served as the Head of the Research and Development Department at ��������ENTEC Diagnostika GmbH from 1992 to 1999, where expertise was gained in molecular biology, autoimmunity product development, quality control, and marketing. Torsten Matthias earned a Doctor's Degree in Biochemistry and Gene Technology from Bielefeld University and a Doctor's Degree in Physical Biochemistry from Technische Universität Dresden.